The results of the CD4+ T population differed completely, as patients who did not achieve MPR appeared to have a lower tumor-infiltration of CD4+ T cells (p = 0.043 in NAPC patients), although differences for NAC patients were not statistically significant (p = 0.16 in NAPC, Figure 7D). This evidence concerns the gene CD4 and neoplasm.